|Articles|November 1, 2017
- Pharmaceutical Executive-11-01-2017
- Volume 37
- Issue 11
Pharmaceutical Executive, November 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharm Exec's 2018 Pipeline Reportalmost 8 years ago
Taiwan’s Biotech Boomalmost 8 years ago
The Fine Line of Pharma & Patient Group Collaborationalmost 8 years ago
FDA Explores Flexible Drug Marketing Policiesalmost 8 years ago
No Overnight Successesalmost 8 years ago
Aligning Early Advice with Long-Term Planningalmost 8 years ago
Navigating the Untapped NASH Marketalmost 8 years ago
Interpreting UK’s Post-Brexit Life Sciences Strategyalmost 8 years ago
When HIPAA Doesn’t Applyalmost 8 years ago
Country Report: AustriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
Advancing Neuroscience and Rare Disease Innovation
3
How are Updates to FDA's Processes Impacting Medical Affairs Teams?
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
